Select Medical Holdings Corporation vs 22nd Century Group Inc — how do they compare? Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: Select Medical Holdings Corporation is far larger — about 1375.8× 22nd Century Group Inc's market cap, and Select Medical Holdings Corporation pays a 1.51% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| SEM | XXII | |
|---|---|---|
Market Cap | $2.05B | $1.49M |
Sector | Health | Technology |
52-Week High | $16.66 | $1.07K |
52-Week Low | $11.77 | $3.90 |
Enterprise Value | $5.01B | -$6.74M |
Dividend Yield | 1.51% | — |
Signals from Pluang's Aura AI — not financial advice
Select Medical (SEM) trades at $16.51, unchanged on the day, amid a completed acquisition by a consortium led by Robert A. Ortenzio and Martin F. at $16.50 per share. The stock shows a bullish technical signal with support and resistance clustered around $17. Financially, the company reported 2025 revenue of $5.45B and net income of $146.22M, with a P/E of 15.43 and P/S of 0.36 indicating moderate valuation. Recent earnings have been mixed, with a beat in Q3 2025 but misses in Q4 2025 and Q1 2026.
The acquisition at $16.50 per share caps near-term upside, with legal investigations into the board's fiduciary duties posing a key risk. Analyst sentiment is mixed with 35.71% buy ratings but 57.15% hold, reflecting uncertainty post-buyout. Investors should note the stock's limited movement potential given the acquisition price, with fundamental performance and legal outcomes driving any residual value.
No Aura AI signal available yet.
Trailing returns across standard periods
Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.
Read more on SEM →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →